Lexeo Therapeutics, Inc.'s total assets for Q2 2025 were $176.07M, an increase of 40.08% from the previous quarter. LXEO total liabilities were $37.85M for the fiscal quarter, a 0.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.